Analysts: Axa SA (AXAF.PA)
15.17EUR
22 May 2013
€0.14 (+0.97%)
€15.02
€15.05
€15.20
€15.01
7,789,754
7,949,625
€15.23
€8.65
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 1.99 | December | 22 May 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 10 | 9 | 9 | 10 |
| (2) OUTPERFORM | 13 | 13 | 13 | 12 |
| (3) HOLD | 3 | 4 | 4 | 5 |
| (4) UNDERPERFORM | 4 | 4 | 4 | 4 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.03 | 2.10 | 2.10 | 2.10 |
Consensus Estimates Analysis
Earnings and Dividend Figures in Euro (EUR)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Dec-13 | 17 | 92,990.40 | 114,494.00 | 85,982.00 | 92,902.40 |
| Year Ending Dec-14 | 15 | 95,495.80 | 117,994.00 | 87,401.00 | 95,732.50 |
| Earnings (per share) | |||||
| Quarter Ending Dec-13 | 1 | 1.99 | 1.99 | 1.99 | 2.07 |
| Quarter Ending Dec-14 | 1 | 2.13 | 2.13 | 2.13 | -- |
| Year Ending Dec-13 | 30 | 1.93 | 2.20 | 1.61 | 2.03 |
| Year Ending Dec-14 | 26 | 2.08 | 2.28 | 1.66 | 2.17 |
| LT Growth Rate (%) | 8 | 7.91 | 17.80 | 5.00 | 9.92 |
Historical Surprises
Earnings and Dividend Figures in Euro (EUR)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Sep-11 | 18,849.00 | 19,109.00 | 260.00 | 1.38 |
| Quarter Ending Mar-11 | 28,413.60 | 27,923.00 | 490.60 | 1.73 |
| Quarter Ending Sep-10 | 20,173.00 | 20,537.00 | 364.00 | 1.80 |
| Quarter Ending Mar-10 | 27,879.00 | 27,910.00 | 31.00 | 0.11 |
| Quarter Ending Sep-09 | 13,405.00 | 19,663.00 | 6,258.00 | 46.68 |
Consensus Estimates Trend
Earnings and Dividend Figures in Euro (EUR)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Dec-13 | 92,990.40 | 94,969.20 | 95,462.10 | 95,644.20 | 92,902.40 |
| Year Ending Dec-14 | 95,495.80 | 94,974.50 | 93,564.60 | 94,648.50 | 95,732.50 |
| Earnings (per share) | |||||
| Quarter Ending Dec-13 | 1.99 | 1.99 | 2.03 | 2.03 | 2.07 |
| Quarter Ending Dec-14 | 2.13 | 2.13 | 2.13 | 2.13 | -- |
| Quarter Ending Dec-13 | 1.93 | 1.92 | 1.95 | 1.95 | 2.03 |
| Quarter Ending Dec-14 | 2.08 | 2.08 | 2.11 | 2.11 | 2.17 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Year Ending Dec-13 | 1 | 0 | 3 | 0 |
| Year Ending Dec-14 | 0 | 0 | 1 | 0 |
| Earnings | ||||
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-14 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 1 | 0 | 3 | 5 |
| Year Ending Dec-14 | 0 | 0 | 2 | 3 |
Earnings vs. 
Estimates- AXA Q1 sales rise 3 pct, helped by asset management
- Fitch Affirms AXA Entities' IFS at 'AA-'; Outlook Negative
- UPDATE 1-Unipol says Allianz, Axa, Zurich, eyeing assets
- Unipol says Allianz, Axa, Zurich, others interested in its assets
- Update-Moody's affirms AXA's A2 senior debt rating with a negative outlook
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Finlabo SIM Spa
|
$58.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Validea
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
